Scientists used a bacterial system called retron to turn DNA into a programmable tool inside living cells, enabling gene ...

Researchers developed a retron-based system that enables DNA to function as an active intracellular tool rather than merely ...

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...

Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...

In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as pivotal players, offering new avenues for understanding the fine-tuned ...

Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a ...

Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have defined a new genetic disease marked by premature aging and deficits in brain function.

Two decades of cloning experiments in mice have produced a striking pattern: animals created through somatic cell nuclear ...